NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.27% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.05% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.05% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.04% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.77% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.72% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.69% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.55% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.49% |
| ANIP | ANI Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.38% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 3.17% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.17% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 3.09% |
| INVA | Innoviva Inc | Healthcare | Biotechnology | 3.06% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.04% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 3.02% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.98% |
| PCRX | Pacira BioSciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 2.96% |